Therefore, advisably inhibiting PTP1B activity is considered to evoke multiple series of physiological responses to resist T2DM and obesity via facilitating tyrosine phosphorylation of insulin signaling molecules. This evidence concerns the gene INS and type 2 diabetes mellitus.